E3 protein ligases enhance transfer of ubiquitin-like (Ubl) proteins from E2 conjugating enzymes to substrates by stabilizing the thioester-charged E2~Ubl in a closed configuration optimally aligned for nucleophilic attack. Here, we report biochemical and structural data that define the N-terminal domain of the Homo sapiens ZNF451 as the catalytic module for SUMO E3 ligase activity. The ZNF451 catalytic module contains tandem SUMO-interaction motifs (SIMs) bridged by a Pro-Leu-Arg-Pro (PLRP) motif. The first SIM and PLRP motif engage thioester-charged E2~SUMO while the next SIM binds a second molecule of SUMO bound to the back side of E2. We show that ZNF451 is SUMO2 specific and that SUMO modification of ZNF451 may contribute to activity by providing a second molecule of SUMO that interacts with E2. Our results are consistent with ZNF451 functioning as a bona fide SUMO E3 ligase. npg
a r t i c l e s Ubiquitin (Ub) and ubiquitin-like (Ubl) proteins regulate numerous cellular processes (reviewed in ref. 1) and are typically conjugated to lysine residues of substrate proteins by the sequential activities of an E1 activating enzyme, an E2 conjugating enzyme and E3 ligases, which facilitate Ub or Ubl transfer from the charged E2 to target substrates (reviewed in ref. 2) . The SUMO pathway includes a single E1, a single E2 and several E3s. SUMO conjugation can occur in the absence of an E3 via E2 recognition of a Ψ-K-X-E substrate consensus motif, in which K is the target lysine, and Ψ is a hydrophobic residue 3, 4 . Three genes encode unique SUMO proteins in humans. SUMO2 and SUMO3 share 97% sequence identity in their mature form and include an N-terminal Ψ-K-X-E substrate consensus motif, which is used to form SUMO chains 5 . SUMO1 is present in cells at lower abundance 6 , shares 50% sequence identity with SUMO2 and SUMO3 and does not efficiently form chains 5 .
E3 ligases can decrease the binding constant for substrate while increasing the rate of transfer, thus resulting in an increase in the specificity constant (rate constant/binding constant). Mechanistically, E3 ligases stimulate Ub D or Ubl D~E 2 thioester discharge (in which D denotes the donor Ub or Ubl, and tilde denotes a covalent bond) by positioning Ub D or Ubl D in a closed and active conformation primed for conjugation (reviewed in ref. 2) . This was first demonstrated for the SUMO E3 ligase RANBP2 (ref. 7) . Subsequent analysis of the Ub~UBCH5-BRCA1-BARD1 complex by NMR has suggested a closed conformation for Ub 8 . Several structures and biochemical characterization of ubiquitin and NEDD8 E3 ligases have also been reported wherein the Ub D or Ubl D~E 2 is arranged in a similar closed configuration, albeit one stabilized by interactions that are unique to the ubiquitin and NEDD8 RING E3 ligase systems 7, [9] [10] [11] [12] [13] [14] [15] . This mechanism is also used by certain Ub E2s that induce a closed configuration in the absence of E3 (ref. 16, 17) .
A few bona fide SUMO E3 ligases have been identified. Siz and PIAS proteins belong to the SP-RING family of E3 ligases, which use a RING domain to interact with the charged E2 (refs. 18, 19) . RANBP2 belongs to a second class of SUMO E3 ligases that coordinate the charged E2 by using the IR1-M-IR2 motif 20 , wherein each IR constitutes a catalytic module that includes a SIM, which binds SUMO D in the context of thioester-charged SUMO D~E 2, and additional structural elements that engage the interface between SUMO D and E2 before wrapping around the back side of the E2 (ref. 7) . SIMs are short motifs typically composed of four hydrophobic residues succeeded or preceded by acidic residues that bind SUMO through β-strand complementation with SUMO's β-sheet in parallel or antiparallel orientation 7, [21] [22] [23] . Other SUMO E3 ligases have been proposed; however, their mechanism of action remains elusive. Some of these, such as PC2 and SLX4, possess multiple SIMs and appear to stimulate SUMO conjugation in a SIM-dependent manner [24] [25] [26] [27] .
In addition to interacting with SUMO D , the SUMO E2 UBC9 can interact with a second molecule of SUMO through noncovalent interactions on the opposite surface or back side of E2, thereby forming an E2-SUMO B complex [28] [29] [30] [31] [32] , in which B denotes interaction with the back side of the E2. E2-SUMO B interactions in the SUMO pathway are structurally analogous to those observed for E2-Ub B complexes in the ubiquitin pathway, as exemplified by UBCH5-Ub B , RAD6-Ub B and MMS2-Ub B (refs. [33] [34] [35] . The UBCH5-Ub B noncovalent interaction has been shown to be important for increasing the rate of chain formation 33 , and a similar role has been proposed for the UBC9-SUMO B interaction 30, 32, 35 . Although E2-Ub B and E2-SUMO B interactions are structurally similar, a notable difference between them is that E2-SUMO B binding is estimated at ~100 nM affinity 29, 32 , whereas E2-Ub B interaction occurs with affinities measured at >100 µM (refs. 10, 33) .
Recent work has also suggested that E2-Ub B interaction may stimulate Ub D conjugation through an allosteric mechanism 10 ; however, it remains unclear whether this is true for E2-SUMO B interaction.
Several lines of evidence have suggested that ZNF451 may constitute another class of SUMO E3 ligase. ZNF451 includes two predicted N-terminal SIMs followed by 12 C 2 H 2 zinc-finger domains and a ubiquitin-interacting motif ( Fig. 1a ). ZNF451 interacts with SUMO and SUMO-conjugating enzymes, and it localizes to PML nuclear bodies in a SUMO-dependent manner 36 . ZNF451 is targeted by SUMO modification on multiple lysine residues 3,37-40 , and ZNF451 modification has been shown to occur in vitro in a SIM-dependent manner 36 . To understand whether ZNF451 is a bona fide SUMO E3 ligase, we performed structural and biochemical analyses and, along with Eisenhardt et al. 41 , show that an N-terminal ZNF451 domain encompassing tandem SIMs and an intervening PLRP motif catalyzes SUMO E3 ligase activity with a preference for SUMO2. We establish that ZNF451 preferentially interacts with SUMO D~E 2-SUMO B rather than SUMO D~E 2 or E2-SUMO B . The first SIM engages SUMO D , the second SIM engages SUMO B , and the intervening PLRP motif wedges into the interface between SUMO D and SUMO B , thus establishing contacts to the E2. Similarly to other E3 complexes, ZNF451 increases the rate of catalysis by coordinating thioester-charged SUMO D~E 2 in an activated 'closed' configuration, and it increases the binding affinity for substrates. We further show that SUMO-modified ZNF451 can bypass the requirement for exogenous SUMO B , presumably because SUMO-modified ZNF451 provides the additional molecule of SUMO in cis.
RESULTS

ZNF451 N-terminal domain catalyzes SUMO2 E3 ligase activity
To quantitatively assess whether the N-terminal domain of ZNF451 displays SUMO E3 ligase activity in vitro, we monitored conjugation of SUMO2 ( Fig. 1b and Supplementary Table 1 ) and SUMO1 ( Fig. 1c and Supplementary Table 1 ) to the model substrate p53 in the absence or presence of an N-terminal domain of ZNF451 encompassing the two SIMs within residues 2-56. These assays, performed in single-turnover conditions, revealed that ZNF451 2-56 enhanced conjugation to p53 with SUMO2 and SUMO1 by factors of 22 and 10, respectively, through a decrease in K d and an increase in k 2 . To explore whether ZNF451 binds to SUMO D~E 2-SUMO B more strongly than to SUMO D~E 2, we repeated assays in the presence of exogenous SUMO. SUMO2 and SUMO1 include the SUMO Ubl domain but lack the C-terminal diglycine motif necessary for SUMO conjugation and, in the case of SUMO2, the canonical SUMO consensus acceptor necessary for chain formation 5 . In contrast to UBCH5-Ub B , in which noncovalent interaction modestly increased E2 efficiency in an E3-independent manner 10 , addition of exogenous SUMO1 or SUMO2 in the absence of ZNF451 2-56 resulted in a decrease in SUMO conjugation to p53 by a factor of 2-3. Importantly, whereas exogenous SUMO1 19-94 increased ZNF451 2-56 -dependent activity by a factor of 6, exogenous SUMO2 15-89 increased ZNF451 2-56 -dependent activity with SUMO2 D by a factor of 215, thus suggesting that ZNF451 2-56 has a stronger preference for SUMO2 D~E 2-SUMO2 B than for SUMO1 D~E 2-SUMO1 B . Furthermore, the increase in the specificity constant observed for ZNF451 2-56 with SUMO2 is comparable to the increase of two orders of magnitude in the specificity constant previously observed for RANBP2 with SUMO1 (ref. 7) . Overall, these results suggest that ZNF451 2-56 catalyzes SUMO E3 ligase activity with a distinct preference for SUMO2.
ZNF451 preferentially binds SUMO2 D~U BC9-SUMO2 B
To better understand determinants for ZNF451 recognition of UBC9, SUMO2 B and SUMO2 D , we conducted fluorescence a r t i c l e s npg a r t i c l e s polarization experiments with Alexa488modified ZNF451 . UBC9 interacted with ZNF451 with an apparent K d of 10-16 µM, whereas SUMO2 interacted with ZNF451 with a K d of 120-150 µM ( Fig. 2a,b) . The latter values for interaction with SUMO2 are modestly higher than those reported for other SUMO-SIM interactions, which are in the 1-100 µM range 22, 42, 43 .
To determine how well ZNF451 interacts with thioester-charged SUMO2 D~U BC9, we used two strategies: one used SUMO2 D~R ANGAP1-UBC9 as a mimic of charged E2, and the other used a strategy similar to that used by Plechanovová et al., in which a C93K mutation in UBC9 replaced the thioester bond with a slightly longer but stable SUMO2 D~U BC9 C93K isopeptide bond 14 . ZNF451 interacted with SUMO2 D~U BC9 C93K with a K d of 3 µM. Perhaps consistently with RANGAP1 restricting the motion of SUMO2 D in the context of SUMO2 D~R ANGAP1-UBC9, or with the longer isopeptide in SUMO2 D~U BC9 C93K interfering with binding, ZNF451 bound the SUMO2 D~R ANGAP1-UBC9 complex with a K d of 0.2 µM. To diminish interactions between SUMO2 and the UBC9 back-side surface that might occur in these mixtures, we generated SUMO2 D~U BC9 C93K and SUMO2 D~R ANGAP1-UBC9 with a SUMO2 D63R substitution that disrupts this interface 32 . SUMO2 D D63R~U BC9 C93K and SUMO2 D D63R~R ANGAP1-UBC9 interacted with ZNF451 with apparent K d values of 1.3 µM and 0.4 µM, respectively.
In agreement with the K d of 0.08-0.25 µM observed for the UBC9-SUMO1 B interaction 29,32 , we measured an apparent K d of 0.14 µM for the UBC9-SUMO2 B interaction (Supplementary Fig. 1 ). We next sought to determine how well ZNF451 binds to UBC9-SUMO2 B . In this case, ZNF451 bound UBC9-SUMO2 B with an apparent K d value of 2 µM, a value similar to that observed for SUMO2 D~U BC9 C93K ( Fig. 2a,b) . In a final test, we added exogenous SUMO2 to preparations of SUMO2 D D63R~U BC9 C93K and SUMO2 D D63R~R ANGAP1-UBC9 to generate complexes containing SUMO B . In these cases, ZNF451 interacted with SUMO2 D D63R~U BC9 C93K -SUMO2 B and SUMO2 D D63R~R ANGAP1-UBC9-SUMO2 B with apparent K d values of 0.4 µM and 0.05 µM, respectively-interactions that appeared tighter than those obtained in the absence of SUMO2 B (Fig. 2a,b) . These interactions were specific, as assessed by displacement of the Alexa488-labeled ZNF451-bound complex by unlabeled ZNF451 2-56 for both SUMO2 D D63R~U BC9 C93K -SUMO2 B and SUMO2 D D63R~R ANGAP1-UBC9-SUMO2 B (Fig. 2c,d) . Together, these experiments are fully consistent with a model in which ZNF451 interacts with a thioester-charged SUMO2 D~ UBC9-SUMO2 B in E3 ligase catalysis.
Structure of a ZNF451-RANGAP1~SUMO2 D -E2-SUMO2 B complex
We proposed previously that a SUMO~RANGAP1-E2 complex mimics the active thioester-charged E2~SUMO D conformation in the presence of the E3 ligase RANBP2 (ref. 7) . Subsequent structures in ubiquitin and NEDD8 pathways with Ub or NEDD8 attached to the E2 via isopeptide or ester adducts have validated this hypothesis [10] [11] [12] [13] [14] [15] 44 . Thus, we used RANGAP1~SUMO2 D -UBC9 as a surrogate for SUMO D~U BC9 and obtained crystals of ZNF451-SUMO2~RANGAP1-UBC9 that diffracted to 2.4 Å ( Table 1 and Supplementary Fig. 2a ). The complex contained one ZNF451 molecule and two SUMO2~RANGAP1-UBC9 complexes in the asymmetric unit ( Supplementary Fig. 2b) .
Visual inspection of the structure and analysis of protein contacts in the crystal with PISA 45 (Supplementary Fig. 2c ) revealed that ZNF451 interacts with two molecules of SUMO2, denoted SUMO2 D and SUMO2 B , and one molecule of UBC9. The UBC9 that contacts ZNF451 interacts with SUMO2 D and SUMO2 B , and buries 570 Å 2 and 670 Å 2 of accessible surface, respectively. The other molecule of UBC9 does not interact with ZNF451, and its interaction with SUMO2 B is limited to a region around its active site because it is part of the second SUMO2 B~R ANGAP1-UBC9 complex. The SUMO2 molecule in the second complex is thus donated to the other SUMO2 D~R ANGAP1-UBC9 complex, thereby forming SUMO2 D~R ANGAP1-UBC9-SUMO B . The two UBC9 molecules make minor contacts to each other, burying 238 Å 2 of accessible surface in an apparent lattice contact. The two RANGAP1-UBC9 interfaces are similar to each other and to that previously described 7, 13, 46 . On the basis of interactions observed in the structure and the biochemical studies described earlier, we propose that a biologically relevant complex (Fig. 3a) is composed of one ZNF451, one UBC9 a r t i c l e s and two molecules of SUMO2, with SUMO2 D linked to the substrate RANGAP1 and SUMO2 B coming from the second complex in the asymmetric unit.
As noted above, one molecule of SUMO2 interacts with ZNF451 and adopts a donor (SUMO2 D ) conformation similar to that observed with RANBP2 (ref. 7) (Fig. 3b) while the other SUMO2 molecule interacts with the back side of UBC9 (SUMO2 B ) in a conformation similar to that observed in the UBC9-SUMO1 B noncovalent complex 30 (Fig. 3c) and other UBC9-SUMO complexes 31, 32 . Indeed, alignment of SUMO2 D from ZNF451-SUMO2 D~R ANGAP1-UBC9-SUMO2 B to SUMO2 D of the RANBP2-SUMO2 D~R ANGAP1-UBC9 complex (PDB 3UIN 13 ) resulted in an r.m.s. deviation of 1.3 Å for 76 matched Cα. The largest difference between SUMO2 D moieties was within the C terminus, and omission of the five last residues of SUMO2 from the alignment decreased the r.m.s. deviation from 1.3 to 0.6 Å. When UBC9 was used to align the complexes (Fig. 3b) 
SUMO-SIM interactions
The two ZNF451 SIMs interact with SUMO2 D and SUMO2 B through classical SUMO-SIM interactions, and PISA analysis suggested that both SIM-SUMO2 interfaces are highly similar to each other in terms of interface area, change in Gibbs free energy (∆G i ) and number of hydrogen bonds (Supplementary Fig. 2c ). Despite these similarities, the N-terminal SIM of ZNF451 interacts with SUMO2 D by forming a β-strand that runs antiparallel to the β-sheet of SUMO2 D (Supplementary Fig. 3a) , similarly to the antiparallel orientation observed for the RANBP2-SUMO2 D interaction (ref. 13 and Supplementary Fig. 3b) , and the C-terminal SIM of ZNF451 interacts with SUMO2 B by forming a β-strand that runs parallel to the β-sheet of SUMO2 B (Supplementary Fig. 3c ). In addition to interactions involving main chain hydrogen bonds, there are several side chain contacts between ZNF451 and SUMO2. Notably, ZNF451 Supplementary Fig. 2b) . A black arrow highlights the position of the isopeptide linkage between SUMO2 and RANGAP1. npg a r t i c l e s SIM1 Glu36 and SIM2 Glu44 appear to form salt bridges with Arg50 of SUMO2 D and SUMO2 B , respectively. Furthermore, ZNF451 Gln32 is proximal to Lys33 of SUMO2 D , and ZNF451 Ser35 is proximal to SUMO2 D Gln31. A comparison with RANBP2 revealed overall similarities in SUMO-SIM interactions (Supplementary Fig. 3b ).
The PLRP motif in ZNF451 directly contacts the E2
The two SIMs of ZNF451 are separated by an intervening PLRP motif situated in a composite interface composed of SUMO2 D , UBC9 and SUMO2 B (Fig. 4a) . The interaction between ZNF451 and E2 appears to be centered on an arginine residue that takes part in an intricate network of hydrogen bonds. Indeed, the ZNF451 Arg40 guanidinium is within direct hydrogen-bonding distance of the side chain carboxylate of UBC9 Asp19 and the backbone carbonyl oxygen of UBC9 His20. The guanidinium group of Arg40 is also within hydrogenbonding distance of four water molecules that in turn interact with the side chain carboxylate of UBC9 Asp19, the backbone carbonyl and amide groups of UBC9 His20, the side chain carboxylate of SUMO2 B Asp85 and the backbone carbonyl atom of SUMO2 B Gly24. The two proline residues Pro38 and Pro41 stack on each other, thereby conferring a compact conformation to the PLRP loop. This loop conformation is not uncommon; some PLRP sequences adopt similar structures to that observed in ZNF451 despite being present in different chemical environments (Supplementary Fig. 3d ).
In the case of ZNF451, the PLRP motif appears to confer directionality to binding. In agreement with this hypothesis, the SUMO2 B and SUMO2 D are related by pseudo two-fold symmetry, thus suggesting that SIM interactions could flip to allow N-terminal SIM interactions with SUMO2 B and C-terminal SIM interactions with SUMO2 D . Although a flip in orientation is sterically possible, it would presumably disrupt the intricate network of interactions between ZNF451 Arg40 and UBC9.
To determine whether the PLRP motif is important for SUMO E3 ligase activity, we introduced alanine substitutions in this motif and assayed the resulting proteins for SUMO2 conjugation to p53 in an endpoint assay in single-turnover conditions. Alanine-substitution mutants of ZNF451 Pro38 and Pro41 or Arg40 displayed reduced activity (Fig. 4b) . In contrast, L39A substitution yielded activity similar to that of wild-type. Swapping L39 and R40 (LR to RL) resulted in diminished conjugation activity. To quantify the contribution of Pro38, Pro41 and Arg40 to ligase activity, we selected two mutants for further analysis, ZNF451 ALRA and ZNF451 PLAP ( Fig. 4c and  Supplementary Table 1 ). Alanine substitution of Pro38 and Pro41 disrupted the proline stack and resulted in 2.7% of the wild-type ZNF451 2-56 activity, whereas a mutant with an R40A substitution displayed 3.9% of the wild-type ZNF451 2-56 activity. Although these substitutions did not diminish activity to levels observed in the absence of E3 (although the activity was still higher than in the absence of E3, by a factor of 3-4), these results highlight the importance of the PLRP motif in ZNF451 ligase activity and suggest that Pro38 and Pro41 residues of the PLRP motif are important in maintaining a loop conformation that allows Arg40 to interact with residues of UBC9 and SUMO2 B .
SUMO modification of ZNF451 increases activity
In our structure, the C terminus of ZNF451 is located 8 Å (Cα-Cα distance) from the N terminus of SUMO2 B , thus suggesting that we might be able to provide SUMO2 B as a fusion to ZNF451 to bypass the need for exogenous SUMO2. We generated a chimeric ZNF451 2-55 -SUMO2 and tested its activity. In agreement with our structure and prediction, the rate of SUMO2 conjugation in single-turnover conditions was faster in the absence of exogenous SUMO2 B at every time point for ZNF451 2-55 SUMO2 15-89 compared with ZNF451 2-56 alone (Supplementary Fig. 4) . Notably, at 6.25 µM substrate, the measured rate of 0.065 s −1 with ZNF451 2-55 -SUMO2 15-89 was ~25 times faster than that of ZNF451 2-56 .
Single-turnover assays using the ZNF451 2-55 -SUMO2 15-89 chimeric protein differed from those of ZNF451 and resulted in more complex kinetics reminiscent of substrate inhibition (Supplementary Fig. 4) . To achieve a better comparison between E3s, we used a lysine discharge assay similar to those used for thioester-charged E2~Ub 10, 11, 47 . ZNF451 2-55 -SUMO2 15-89 was three orders of magnitude more active a r t i c l e s than ZNF451 2-56 in lysine discharge assays in the absence of exogenous SUMO2 (Fig. 5a,c and Supplementary Table 2 ). Whereas addition of exogenous SUMO2 to ZNF451 2-56 increased the apparent rate by a factor of 50, addition of SUMO2 to ZNF451 2-55 -SUMO2 had little effect (Fig. 5b,c and Supplementary Table 2 ). Interestingly, fusing ZNF451 to SUMO2 D63R rendered it less active, in either the presence or absence of exogenous SUMO2. These results suggest that SUMO2 D63R , although impaired for E2 binding, may still bind and occlude the second ZNF451 SIM in the context of the ZNF451 2-55 -SUMO2 15-89 D63R fusion and render it insensitive to addition of exogenous SUMO2. Several studies have identified ZNF451 as a substrate for SUMO2 conjugation 3, [37] [38] [39] [40] . Because ZNF451 2-56 does not contain any lysine residues, this construct is not a target for SUMO2 conjugation. We therefore generated a longer ZNF451 2-110 construct containing eight lysine residues, four of which act as SUMO acceptors in vivo 37 . ZNF451 2-110 was efficiently SUMO2 modified in vitro and led to the formation of separable species modified with mono-and poly-SUMO2 (Supplementary Fig. 5 ). Unmodified ZNF451 2-110 displays activities comparable to that of ZNF451 in the presence or absence of exogenous SUMO2 . Similarly to the ZNF451 2-55 -SUMO2 15-89 fusion, monomodified SUMO2 15-93~Z NF451 2-110 was more than two orders of magnitude more active than ZNF451 2-56 for SUMO2 conjugation in the absence of exogenous SUMO2. Analogously to the ZNF451 2-55 -SUMO2 15-89 fusion, the SUMO2 D63R mutation strongly reduced the activity of conjugated SUMO2 15-93 D63R~Z NF451 . These results are consistent with the idea that SUMO2 modification of ZNF451 might increase its apparent activity by providing SUMO B in cis rather than relying on free SUMO for interaction with UBC9.
DISCUSSION
There has been some debate as to whether certain SIM-containing proteins that increase SUMO conjugation are genuine E3 ligases 48 . Similarly to RING-based SUMO E3 ligases and RANBP2, ZNF451 contacts a charged E2 and maintains the donor SUMO in a closed conformation ready for discharge. Furthermore, mutations in the PLRP motif strongly decrease the catalytic efficiency of ZNF451. In other words, two SIMs are not sufficient to convert ZNF451 into a catalyst, and ZNF451 requires contacts with the E2 for activity. This result is in line with our structural data, and it highlights the importance of the PLRP motif in establishing a network of direct and water-mediated interactions with a composite E2-SUMO interface. Together, these results suggest that the catalytic module within ZNF451 constitutes a bona fide member and new class of SUMO E3 ligase.
Buetow et al. have proposed that Ub binding on the back side of thioester-charged UBCH5~Ub increases the catalytic activity of the complex by restricting certain residues in helix α1 and in the α1β1 loop to a position more favorable for catalysis 10 . Analysis of equivalent positions in our structure did not reveal noticeable conformational changes when compared to the 18 human structures of UBC9 that are devoid of SUMO B back-side binding, in agreement with our observation that SUMO2 B binding to thioester-charged SUMO2 D~U BC9 did not increase the activity of the complex. Instead, ZNF451 appears to exploit the high-affinity UBC9-SUMO2 B noncovalent interaction by using its C-terminal SIM as an anchor to interact with SUMO B within SUMO D~E 2-SUMO B while its N-terminal SIM positions SUMO D in conjunction with the PLRP loop, which contacts the E2. This mode of E2 interaction contrasts with that of PIAS proteins, which use an SP-RING domain to physically associate with the E2; however, studies have suggested that interaction with E2-SUMO B may also contribute to the E3 ligase activities of PIAS proteins 49 . Interestingly, ZNF451 uses SUMO B to indirectly interact with the back side of UBC9 in thioester-charged SUMO D~E 2-SUMO B , whereas RANBP2 uses other structural elements beyond its SIM to penetrate the SUMO D~E 2 interface before wrapping additional elements and α-helices around to the back side of the E2.
Our biochemical data suggest that ZNF451 has a preference for SUMO2 over SUMO1. Because modeling SUMO1 in place of 0.5
No SUMO2 Fusion ZNF451 npg a r t i c l e s SUMO2 in our structure did not result in steric occlusion, specificity might result from preferential SUMO2-SIM interactions with SUMO D and/or SUMO B . Alternatively, the ZNF451 SIM-mediated interaction with SUMO1 may result in suboptimal positioning of the PLRP motif, which in turn would result in formation of lessproductive complexes.
A recent comparative analysis of mass spectrometry data has identified more than half of the lysine residues of ZNF451 as SUMOacceptor sites (43 identified sites out of 84 total lysine residues 37 ). Because we have shown that the N-terminal domain of ZNF451 has SUMO E3 ligase activity, it is possible that this domain facilitates SUMO modification of these residues. The previous finding that the N-terminal domain of ZNF451 is SUMO modified in vitro in a SIM-dependent manner is consistent with this idea 36 . Also in line with this idea is the existence of different ZNF451 isoforms that result from alternative splicing. These isoforms share only the first 62 residues of ZNF451, and one of them is followed by a domain that shares sequence similarity with the LAP2α domain 50 . The protein generated by this splicing isoform is also heavily SUMO modified at 17 identified sites out of 32 available lysine residues 37 .
Because the catalytic module of ZNF451 is too small to engage substrates directly, it is likely that other regions of ZNF451 are responsible for contacting exogenous substrates. The observation that three proteins possess the E3 ligase catalytic module of ZNF451 yet differ in their C-terminal domains raises the possibility that these proteins may have different substrate specificities. Furthermore, the N-terminal domain of KIAA1586 shows high sequence identity with the ZNF451 catalytic domain with one notable exception: the leucine residue in the PLRP motif is substituted by serine in KIAA1586. Our mutational data suggest that this position is not important for activity, so it is possible that KIAA1586 may also possess SUMO E3 ligase activity.
Finally, our biochemical data suggest that SUMO modification of ZNF451 2-110 increases its catalytic efficiency, although SUMO modification of other sites or SUMO modification of the same site in the context of full-length ZNF451 may result in different effects. SUMO modification of multiple sites may however eventually decrease ZNF451 ligase activity by masking both SIMs, thus precluding interaction with activated SUMO~E2. Regulation of ZNF451 may be even more complex because 29 of its 43 available SUMO-acceptor lysine residues can also act as Ub-acceptor sites 51 . Finally, two serine residues at the C-terminal end of the second SIM belong to CK2 consensus sites, and phosphorylation of those sites could generate a phospho-SIM and potentiate SUMO-SIM interactions, as observed in other systems 42, 43, 52 .
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